In this study, they identified CD147 as a specificEV-surface protein derived from colorectal cancer cells and revealed that a larger numberof CD9/CD147 double-positive EVs could be detected in serum from colorectal cancerpatients than in serum from healthy control subjects using this assay. The gene discussed is BSG; the disease is colorectal cancer.